华法林停药5天后凝血因子浓度评估
21例INR≤1.2的患者中,95%(99%CI 69%-99%)凝血因子活性大于40%。结论认为INR≤1.2的患者可考虑具备足够凝血因子进行椎管内注射。
要点
- 华法林停药5天后INR≤1.2者,95%凝血因子活性>40%。
- INR 1.3-1.4者例数太少,无法得出结论。
- 凝血因子活性<40%者合并终末期肾病。
核心结论
- 基于凝血因子40%活性阈值,INR≤1.2的患者可认为具备足够凝血因子进行椎管内注射。
- INR为1.3和1.4的患者数量太少,无法得出结论。
研究设计与样本
- 主要终点为凝血因子活性低于40%的受试者频率。
主要发现
- 21例INR≤1.2患者中,因子II、VII、IX、X活性中位数(四分位距)分别为66%(52%-80%)、114%(95%-132%)、101%(84%-121%)、55%(46%-63%)。
- 95%(99%CI 69%-99%)的患者凝血因子活性大于40%。
- 凝血因子活性未大于40%的患者患有终末期肾病。
- 2例INR>1.2者因子II、VII、IX、X活性分别为37%和46%、89%和105%、66%和78%、20%和36%,均未大于40%。
关键数值与推荐
- 美国区域麻醉与疼痛医学学会指南推荐:椎管内注射前停用华法林且INR≤1.2。
- 欧洲和斯堪的纳维亚指南接受INR≤1.4。
- 本研究以凝血因子活性40%作为充分止血的阈值。
临床怎么用
- 华法林停药5天后INR≤1.2的患者,可考虑凝血因子活性足够进行椎管内注射。
- INR 1.3-1.4的患者因证据不足,需个体化评估。
局限性
- INR为1.3和1.4的患者数量太少,无法得出结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American Society of Regional Anesthesia and Pain Medicine guidelines recommend discontinuation of warfarin and an international normalized ratio (INR) of 1.2 or less before a neuraxial injection. The European and Scandinavian guidelines accept an INR of 1.4 or less. We evaluated INR and levels of clotting factors (CFs) II, VII, IX, and X 5 days after discontinuation of warfarin. METHODS: Patients who discontinued warfarin for 5 days and had an INR of 1.4 or less had activities of factors II, VII, IX, and X measured. The primary outcome was the frequency of subjects with CF activities of less than 40%. RESULTS: Twenty-three patients were studied; 21 (91%) had an INR of 1.2 or less. In these 21 patients, the median (interquartile range) activities of factors II, VII, IX, and X were 66% (52%-80%), 114% (95%-132%), 101% (84%-121%), and 55% (46%-63%), respectively. Ninety-five percent (99% confidence interval, 69%-99%) had CF activities of greater than 40%. The patient who did not CF activities greater than 40% had end-stage renal disease. Two subjects had an INR of greater than 1.2; the activities of factor II, VII, IX, and X were 37% and 46%, 89% and 105%, 66% and 78%, and 20% and 36%, respectively. Neither patient had CF activities of greater than 40%. CONCLUSIONS: Based on 40% activity of CFs, patients with INRs of 1.2 or less can be considered to have adequate CFs to undergo neuraxial injections. The number of patients with an INR of 1.3 and 1.4 is too small to make conclusions.
引用
- Benzon HT, Asher Y, Kendall MC, et al. Clotting-Factor Concentrations 5 Days After Discontinuation of Warfarin. Reg Anesth Pain Med. 2018. PMID: 29659439. doi:10.1097/AAP.0000000000000782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。